Sarepta Therapeutics, Inc.

Sarepta Therapeutics, Inc.

13.74
EUR
+0.26
(+1.93%)
0.12EPS
130.48P/E
1.73BMarket Cap
Mar 03Next Earn

Sarepta Therapeutics, Inc. Documents

Q4 FY2020 · Press release

Sarepta Therapeutics Inc - Study Result - Report · 3 pages

Read Sarepta Therapeutics, Inc.'s results firsthand

Preview the first 2 pages of this press release
Create a free account to start reading

Full documents are included with Professional

Q4 FY2020 documents